FDA accepts Sun Pharma’s NDA for deuruxolitinib
October 6, 2023Medical Communications Dermatology, FDA, NDA, SUun Pharma, deuruxolitinib
India-based pharma company Sun Pharmaceutical Industries has announced that the US Food and Drug Administration (FDA) has accepted its New …
FUJIFILM Diosynth Biotechnologies appoints Maja Pedersen as chief quality officer
October 6, 2023Business Services Fujifilm, Fujifilm Diosynth Biotechnologies, Maja Pedersen, Pharmacy, appointment, chief quality officer
CEO and president of FUJIFULM Diosynth Biotechnologies Lars Petersen has appointed Maja Pedersen as chief quality officer, where she will …
Janssen and Sanofi enter agreement for potential vaccine programme
October 5, 2023Business Services Immunology, Janssen, Sanofi, e coli, vaccines
Janssen Pharmaceuticals, a Johnson & Johnson company, has announced a development and commercialisation agreement with Sanofi for Janssen’s extraintestinal pathogenic …
Moderna shares data from phase 1/2 trial for combination flu and COVID-19 vaccine
October 5, 2023Research and Development COVID-19, Immunology, Moderna, clinical trial, influenza, vaccines
Moderna has announced positive interim results from the phase 1/2 trial of mRNA-1083, its investigational combination vaccine against influenza and …
Sanofi and Teva partner for development of inflammatory bowel disease treatment
October 4, 2023Medical Communications Crohn’s disease, Gastrointestinal tract, Sanofi, Teva, bowel disease, ulcerative colitis
Sanofi and Teva Pharmaceuticals have announced that they will collaborate for the co-development and co-commercialisation of TEV’574, a treatment for …
Eli Lilly to acquire POINT Biopharma
October 4, 2023Business Services Eli Lilly, Oncology, POINT Biopharma, acquisition, oncology
Eli Lilly and POINT Biopharma have announced a definitive agreement for Lilly to acquire POINT to expand its pipeline of …
Acurx Pharmaceuticals announces positive data from phase 2b trial for C. difficile infection treatment
October 3, 2023Research and Development Acurx Pharmaceuticals, C. difficile, Infections and infestations, clinical trial, infection
Acurx Pharmaceuticals has announced that it has discontinued its phase 2b clinical trial of its lead antibiotic candidate, ibezapolstat, for …
WHO recommends new vaccine for prevention of malaria in children
October 3, 2023Medical Communications Immunology, Vaccine, WHO, malaria, malaria vaccine
The World Health Organization (WHO) has announced that it has recommended a new vaccine, R21/Matrix-M, for the prevention of malaria …
FDA grants marketing authorisation to DNA test for predisposition to certain cancers
October 2, 2023Research and Development FDA, Invitae, Oncology, cancer testing, oncology
The US Food and Drug Administration (FDA) has granted de novo marketing authorisation to the Invitae Common Hereditary Cancers Panel, …
Biogen’s biosimilar Tofidence approved by FDA
October 2, 2023Medical Communications Actemra, Biogen, FDA, Musculo-skeletal disorder, Tofidence
Biogen has announced that the US Food and Drug Administration (FDA) has approved Tofidence (tocilizumab-bavi) as an intravenous formulation, a …
Austrian state secretary to speak at FlyPharma Europe 2023
September 29, 2023Business Services FlyPharma 2023, Vienna, flypharma
29 September 2023 — London, UK — FlyPharma Europe will welcome Mr Florian Tursky, the Austrian state secretary, to the …
Karuna Therapeutics submits NDA to FDA for schizophrenia treatment
September 29, 2023Medical Communications FDA, Karuna Therapeutics, Neurology, mental health, schizophrenia
Karuna Therapeutics has announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration …
Kura Oncology shares preclinical data for NSCLC treatment
September 29, 2023Medical Communications Kura Oncology, NSCLC, Oncology, oncology
Kura Oncology has shared positive preclinical data which supports the development of its next-generation farnesyl transferase inhibitor (FTI) KO-2806 in …
BactiVac funds development of bacterial vaccines to prevent infections against antimicrobial resistance
September 28, 2023Research and Development AMR, BactiVac, Immunology, vaccines
The University of Birmingham hosted Bacterial Vaccines Network has been awarded £1.4m in funding from the UK government to accelerate …
Avalyn Pharma raises $175m in Series C financing for inhalation therapies
September 28, 2023Business Services Avalyn Pharma, Financing, Pharmacy, funding, inhalation therapies
US-based clinical stage biopharmaceutical company Avalyn Pharma has announced that it has raised $175m in Series C financing to continue …
NMD Pharma begins phase 2 trial for spinal muscular atrophy treatment
September 27, 2023Research and Development Musculo-skeletal disorder, NMD Pharma, clinical trial, spinal muscular atrophy
NMD Pharma has announced that the first patient has been dosed in its phase 2 clinical trial for its CIC-1 …
Alfasigma to acquire Intercept Pharmaceuticals for $19 per share
September 27, 2023Business Services Alfasigma, Gastrointestinal tract, acquisition
Alfasigma and Intercept Pharmaceuticals have announced that they have entered into a definitive merger agreement, meaning Alfasigma will acquire Intercept …
Regeneron and Sanofi’s sBLA for Dupixent accepted by FDA for priority review
September 26, 2023Medical Communications Dupixent, Ear Nose & throat, FDA, Regeneron, Sanofi
Regeneron Pharmaceuticals and Sanofi have announced that the US Food and Drug Administration (FDA) has accepted their supplemental Biologics License …
Acesion Pharma raises €45m series B funding
September 26, 2023Business Services Acesion Pharma, Cardiology, atrial fibrillation, series B financing
Acesion Pharma has announced that it has closed an oversubscribed €45m series B financing round. This financing was co-led by …
CDC Advisory Committee recommends Pfizer’s RSV vaccine
September 25, 2023Medical Communications Abrysvo, Immunology, Pfizer, RSV
Pfizer has announced that the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
